• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Christian Bär, Germany

    Christian Bär, Germany

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Olga, Argentina

    Olga, Argentina

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Jon Newsome, USA

    Jon Newsome, USA

  • Mona H. Bahus and Camilla Knoff Glomstad, Norway

    Mona H. Bahus and Camilla Knoff Glomstad, Norway

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Anna Barrow, UK

    Anna Barrow, UK

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Willi Klein, UK

    Willi Klein, UK

  • Michael Lee, Australia

    Michael Lee, Australia

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • David Bishop, UK

    David Bishop, UK

  • Art Eggert, USA

    Art Eggert, USA

  • David Watson, Scotland

    David Watson, Scotland

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Anita Forte, USA

    Anita Forte, USA

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Daniel Hare, USA

    Daniel Hare, USA

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • John Dinon, Australia

    John Dinon, Australia

  • Bob Simonds, USA

    Bob Simonds, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login